Veracyte (VCYT) Return on Sales (2012 - 2026)

Veracyte has reported Return on Sales for 15 years, with the latest figure at 0.0% in Q2 2026.

• Return on Sales for Q2 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Sales eased to 0.0% in Q2 2026, from 0.0% in the prior quarter.
• Over five years, Return on Sales peaked at 0.0% in Q4 2025 and troughed at 0.0% in Q3 2023.
• A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Sales.
• The largest YoY upside for Return on Sales was 1 bps in 2022 against a maximum downside of 0 bps in 2022.
• A 5-year view of Return on Sales shows it stood at 0.0% in 2022, then tumbled by 497 bps to 0.0% in 2023, then soared by 115 bps to 0.0% in 2024, then jumped by 576 bps to 0.0% in 2025, then sank by 42 bps to 0.0% in 2026.
• Per Business Quant data, the three most recent Return on Sales figures were 0.0% in Q2 2026, 0.0% in Q1 2026, and 0.0% in Q4 2025.